Discussione: Consiglio di amministrazione Botoxina
| Autore | |
| Fabio71 | Caro Giorgio, guarda cosa sono riuscito a trovare! Ti invio in allegato una copia del consiglio di amministrazione della Botoxina. After having rejected the new acquisition proposals the, the board of directors of Ermes, licensor of β0toxinA in reasserting its own independence voted unanimously against the possibility that for at least the next 15 years that the new investements and capital injected by new shareholders and CCDL BANK owner of 25% common stock should go towards the financing of the long awaited new plant that would have brought β0toxinA from an èlite niche (which the company allows release by the licensor only after the administration of very involved questionnaires and only in case of proven necessity) to a more heavily industrialised large scale production. All efforts over the next years will go towards research in Alzheimer's disease, diabetes and other more pathologies rather than than wrinkles and no major distribution contracts will be entered into for the esthetic medicine market nor shall efforts be made to increase production which shall remain miniscule with respect to the expected demand for so many years. Also voted against was the possibile merger with the major licensees of β0toxinA Topica which until yesterday seemed to be linked to the production of β0toxinA Injectable. In an age when cross allergies and intolerances also from foods and pollution, "The company must respond to the precise objective of guaranteeing military supplies in case of a national emergency" commented Fred Johnson, corporate spokesman. So ends, without much ado, a series of plans and proposals from many groups around the world, who have popped up in the past 8 years, aimed at taking control of the facility, which boasts the planet’s most complete C. botulinum toxin production also for medical applications which a few succeeded with in the florid esthetic medicine market. Many investors disgruntled by their penalisation by the current military oriented board which by sbattute periodically destroys warehoused lots 3 months before expiry. Be it for burocracy or politics, the decision is final. "The company", says Johnson, "proud of its research carried out in our undersea mobile laboratories supporting the floating one, has described the properties of some 3000 rare algae. Work that is unique and achieved though Sealab's sub which has fathomed the unexplored depths to examine those seabeds and to reveal many as yet unviolated mysteries." Johnson who boasts as yet secret agreements with many cosmetic firms to exploit the research carried out, which will bring the company an after tax profit of about 30.000.000 US.dollars. (GB Pounds?, Euros?) "Part of the research defined as not commercially, but scientifically, interesting," he said, "shall be donated to the WHO." Roberto Hackensack-Castro |
| Giorgio | Quindi neanche nei prossimi anni riusciremo a trovare botoxina nei nostri paesi... |
| TORNA ALL'INDICE | |